Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Other Non Operating Income came in at -$10.0 million in Q4 2025, up 15.27% year-on-year from -$8.7 million in Q4 2024, and down 1897.01% quarter-over-quarter from -$501000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Non Operating Income history runs 16 years deep, the most recent figure standing at -$10.0 million for Q4 2025.
- On a quarterly basis, Other Non Operating Income rose 15.27% year-over-year to -$10.0 million in Q4 2025; TTM through Dec 2025 was -$14.0 million, a 154.35% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 55144.44% from the prior year.
- Other Non Operating Income slipped to -$10.0 million in Q4 2025 per PBH's latest filing, from -$501000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $51.6 million in Q1 2024 and bottomed at -$91.0 million in Q1 2021.
- The 5-year median for Other Non Operating Income is -$2.4 million (2022), against an average of -$10.7 million.
- Across the five-year window, Other Non Operating Income plunged 149620.0% in 2021 and soared 11337.25% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$17.1 million in 2021, then soared by 93.28% to -$1.2 million in 2022, then jumped by 40.7% to -$682000.0 in 2023, then tumbled by 1631.38% to -$11.8 million in 2024, then climbed by 15.27% to -$10.0 million in 2025.
- Per Business Quant, the three latest PBH Other Non Operating Income figures stand at -$10.0 million (Q4 2025), -$501000.0 (Q3 2025), and $224000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.41 Bn | 2.35 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.01 Mn |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -395,000.00 |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | 51.58 Mn |
| Dec 31, 2023 | -682,000.00 |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 451,000.00 |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | -812,000.00 |
| Jun 30, 2022 | 790,000.00 |
| Mar 31, 2022 | -65.34 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Sep 30, 2021 | -18.93 Mn |
| Jun 30, 2021 | -14.97 Mn |
| Mar 31, 2021 | -90.96 Mn |